URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


2nd Annual Gene Therapy Medical Affairs


Date
Apr 19, 2022 - 08:00 AM - Apr 21, 06:00 PM
Organizer
Hanson Wade
Venue
The Westin Boston Seaport District
Location
425, Summer St

Boston,
MA,
USA,
ZIP: 02210
Phone: +442031418700

Ticket Price: Conference + 3 Workshops: USD 4946.0, Conference + 2 Workshops: USD 4297.0, Conference + 1 Workshop: USD 3648.0, Conference Only: USD 2999.0

The 2nd Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role Medical Affairs plays in delivering gene therapies to patients.

Whilst Gene Therapies are set to transform treatment paradigms, their complex nature and high price tag presents unique challenges. Learn how the global leaders of the gene therapy world are transforming the traditional role of medical affairs, from reactive to proactive strategic partners to launch gene therapy products more efficiently and effectively than ever before.

Join Orchard Therapeutics, PTC Therapeutics, Sanofi Genzyme and others as we start to define both the role and value of Medical Affairs from early development of gene therapies right the way to a launch environment.

Whether it is learning how to educate and upskill cross-functional teams or tailoring engagement strategies with external HCPs, regulators and patient advocates, join us to determine how best to create a cohesive and streamlined launch strategy specifically for gene therapy products.

We will delve into the unique challenge encountered when working with gene therapies, from adapting to the clinical realities of the rare disease space to handling long-term follow up and post-launch regulatory scrutiny, equipping you with the insights required to for a successful and patient-centric launch.

Group discounts and early booking rates are available. Please visit the website for full pricing information.

URLs:
Tickets: https://go.evvnt.com/962696-2?pid=1052
Brochure: https://go.evvnt.com/962696-3?pid=1052



Speaker Details


Kent Christopherson, Senior Director US Medical Affairs, Orchard Therapeutics, Ian Winburn, Global Medical Lead Haemophillia, Pfizer, Alexis Russell, Senior Director, US Gene Therapy, Therapeutic Area Lead PTC Therapeutics, Catherine Parham, Vice President, Head of Global Medical Affairs, Astellas Gene Therapies, Fatima Ahmad Vice President, Medical Affairs, Castle Creek Biosciences, Kathrin Kucharski, Senior Director Medical, Managed Care, Sarepta Therapeutics, Oscar Segurado, Chief Medical Officer, ASC Therapeutics, Ruth Haile-Meskale, Medical Science Liaison Lead, Gene Therapy, Hematology, Spark Therapeutics, Sandra Casiano, Senior Medical Director, Sanofi Genzyme

Event Categories
Keywords: pharmaceutical




Comments








Events Calendar

SunMonTueWedThuFriSat
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99